Martin Mackay news from FierceBiotech
NewsPfizer spins off Esperion as VCs ante up $22.75M
Pfizer has spun of Esperion Therapeutics into a new biotech company aiming to develop new therapies for cardiovascular and metabolic disease. A syndicate of investors funded the deal. Pfizer sold Read more...
Pfizer hires new R&D chief, launches biotech center
Pfizer is making moves to salvage its troubled pipeline. The company has named Martin Mackay as its new Read more...
| Press ReleasesPRESS RELEASE: Dr. Martin Mackay Named President of Pfizer Global Research and Development Dr. Martin Mackay Named President of Pfizer Global Research and Development Pfizer Launches Independent Biotherapeutics and Bioinnovation Center, Headed by Dr. Corey Goodman Dr. Briggs Morrison Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends